Additionally, phototherapeutic nano-PROTACs, like those targeting COX-1/2 and activated by tumor-overexpressed cathepsin B, enhance tumor-specific protein degradation, reprogram the tumor microenvironment (TME), and stimulate immune responses, further suppressing tumor growth (Gao et al., 2024). This evidence concerns the gene CTSB and neoplasm.